Innovative approaches in CNS drug discovery.

Journal: Therapie
PMID:

Abstract

Central nervous system disorders remain the leading causes of mortality and morbidity worldwide, affecting more than 1 billion patients. This therapeutic area suffers from high unmet medical needs and the search for innovative approaches to identify therapeutic strategies is urgent in the field. This review will first cover the challenges and opportunities of drug discovery in neurology, and then as well as the new models, such as human model stem cells and animal models under development in the field. In addition, innovative and translational neuroimaging techniques will be discussed, as the use of big data and artificial intelligence to discovery new drugs in neurological and neuropsychiatric disorders.

Authors

  • Mathieu Charvériat
    Theranexus, 69008 Lyon, France. Electronic address: mathieu.charveriat@theranexus.com.
  • Vincent Lafon
    Insiliance, 75014 Paris, France.
  • Franck Mouthon
    Theranexus, 69008 Lyon, France.
  • Luc Zimmer
    Université de Lyon, 69675 Lyon, France; Hospices civils de Lyon, 69500 Bron, France.